Aurora Cannabis Inc. (ACB) vs Alpha Teknova, Inc. (TKNO)

Aurora Cannabis Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $408.0M against $265.8M — 1.5× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 12.3% against −18.2%. Aurora Cannabis Inc. has the higher net margin (−38.1% vs −38.4%) and the higher return on invested capital (−5.58% vs −16.9%). Across the 18 metrics below, Aurora Cannabis Inc. leads on 11 and Alpha Teknova, Inc. on 7.

Valuation

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 1.17 8.69 2.11
P/B 0.65 6.07 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 0.93 8.69 2.73
Earnings yield (35.34%) (4.38%) (4.38%)
Free cash flow yield (14.67%) (1.94%) 0.00%

Profitability

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 34.60% 53.94%
Operating margin (12.13%) (36.19%) 0.00%
Net margin (38.12%) (38.37%) 0.00%
Free cash flow margin (17.19%) (16.83%) 0.00%
Return on equity (19.85%) (24.19%) (0.40%)
Return on assets (15.19%) (16.25%) (3.32%)
Return on invested capital (5.58%) (16.93%) 0.00%

Growth

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 12.27% 10.01%
EPS growth (last fiscal year) (5,266.67%) 43.86% 49.06%
Revenue growth, 5-year CAGR 3.92% 5.30% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.21 0.05
Current ratio 5.36 4.49 2.31
Net debt to EBITDA 5.11 0.75 0.97

Dividend

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric ACB TKNO Drug Manufacturers Specialty & Generic median
Market cap 265.84m 408.03m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack